Indications of Th1 and Th17 responses in cerebrospinal fluid from patients with Lyme neuroborreliosis: A large retrospective study

Journal of Neuroinflammation

Volumn 8, Issue , 2011, Pages

  Henningsson, Anna J ^a   Tjernberg, Ivar ^b   Malmvall, Bo Eric ^a,c   Forsberg, Pia ^c   Ernerudh, Jan ^c  

^a RYHOV COUNTY HOSPITAL   (Sweden)

^b KALMAR COUNTY HOSPITAL   (Sweden)

^c LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BACTERIUM ANTIBODY; BIOLOGICAL MARKER; CHEMOKINE; CYTOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 17; INTERLEUKIN 8; MACROPHAGE DERIVED CHEMOKINE; CCL22 PROTEIN, HUMAN; CXCL10 PROTEIN, HUMAN; IL8 PROTEIN, HUMAN;

ADOLESCENT; AGED; ARTICLE; CELLULAR IMMUNITY; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; CYTOKINE RESPONSE; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; LYME DISEASE; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; RETROSPECTIVE STUDY; SPINAL ANESTHESIA; SYMPTOM; TH1 CELL; TH17 CELL; ADULT; BLOOD; BORRELIA BURGDORFERI; CEREBROSPINAL FLUID; IMMUNOLOGY; MIDDLE AGED; TH2 CELL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BORRELIA BURGDORFERI GROUP; CHEMOKINE CCL22; CHEMOKINE CXCL10; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INTERLEUKIN-17; INTERLEUKIN-8; LYME NEUROBORRELIOSIS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TH1 CELLS; TH17 CELLS; TH2 CELLS; YOUNG ADULT;

EID: 79954598191     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-8-36     Document Type: Article

References (46)

1. Berglund J, Eitrem R, Ornstein K, Lindberg A, Ringér A, Elmrud H, Carlsson M, Runehagen A, Svanborg C, Norrby R. An epidemiologic study of Lyme disease in southern Sweden. N Engl J Med 1995, 333:1319-27. 10.1056/NEJM199511163332004, 7566023.
2. Cimmino MA. Relative frequency of Lyme borreliosis and of its clinical manifestations in Europe. European Community Concerted Action on Risk Assessment in Lyme Borreliosis. Infection 1998, 26:298-300. 10.1007/BF02962251, 9795788.
3. Oschmann P, Dorndorf W, Hornig C, Schäfer C, Wellensiek HJ, Pflughaupt KW. Stages and syndromes of neuroborreliosis. J Neurol 1998, 245:262-72. 10.1007/s004150050216, 9617706.
4. Kaiser R. Neuroborreliosis. J Neurol 1998, 245:247-55. 10.1007/s004150050214, 9617704.
5. Weber K. Aspects of Lyme borreliosis in Europe. Eur J Clin Microbiol Infect Dis 2001, 20:6-13.
6. Berglund J, Stjernberg L, Ornstein K, Tykesson-Joelsson K, Walter H. 5-year follow-up study of patients with neuroborreliosis. Scand J Infect Dis 2002, 34:421-5. 10.1080/00365540110080421, 12160168.
7. Vrethem M, Hellblom L, Widlund M, Ahl M, Danielsson O, Ernerudh J, Forsberg P. Chronic symptoms are common in patients with neuroborreliosis - a questionnaire follow-up study. Acta Neurol Scand 2002, 106:205-8. 10.1034/j.1600-0404.2002.01358.x, 12225315.
8. Tjernberg I, Carlsson M, Ernerudh J, Eliasson I, Forsberg P. Mapping of hormones and cortisol responses in patients after Lyme neuroborreliosis. BMC Infect Dis 2010, 10:20. 10.1186/1471-2334-10-20, 2827415, 20137075.
9. Forsberg P, Ernerudh J, Ekerfelt C, Roberg M, Vrethem M, Bergström S. The outer surface proteins of Lyme disease Borrelia spirochetes stimulate T cells to secrete interferon-gamma (IFN-γ): diagnostic and pathogenic implications. Clin Exp Immunol 1995, 101:453-60. 1553228, 7664493.
10. Widhe M, Grusell M, Ekerfelt C, Vrethem M, Forsberg P, Ernerudh J. Cytokines in Lyme Borreliosis: lack of early tumor necrosis factor-alpha and transforming growth factor-beta 1 responses are associated with chronic neuroborreliosis. Immunology 2002, 107:46-55. 10.1046/j.1365-2567.2002.01500.x, 1782772, 12225362.
11. Sjöwall J, Carlsson A, Vaarala O, Bergström S, Ernerudh J, Forsberg P, Ekerfelt C. Innate immune responses in Lyme borreliosis: enhanced tumor necrosis factor-alpha and interleukin-12 in asymptomatic individuals in response to live spirochetes. Clin Exp Immunol 2005, 141:89-98. 10.1111/j.1365-2249.2005.02820.x, 1809414, 15958074.
12. Oksi J, Savolainen J, Pène J, Bòusquet J, Laippala P, Viljanen MK. Decreased interleukin-4 and increased gamma interferon production by peripheral blood mononuclear cells of patients with Lyme borreliosis. Infect Immun 1996, 64:3620-3. 174272, 8751908.
13. Ekerfelt C, Ernerudh J, Bunikis J, Vrethem M, Aagesen J, Roberg M, Bergström S, Forsberg P. Compartmentalization of antigen specific cytokine responses to the central nervous system in CNS borreliosis: secretion of IFN-gamma predominates over IL-4 secretion in response to outer surface proteins of Lyme disease Borrelia spirochetes. J Neuroimmunol 1997, 79:155-62. 10.1016/S0165-5728(97)00118-5, 9394788.
14. Widhe M, Ekerfelt C, Forsberg P, Bergström S, Ernerudh J. IgG subclasses in Lyme borreliosis: a study of specific IgG subclass distribution in an interferon-gamma-predominated disease. Scand J Immunol 1998, 47:575-81.
15. Ekerfelt C, Jarefors S, Tynngård N, Hedlund M, Sander B, Bergström S, Forsberg P, Ernerudh J. Phenotypes indicating cytolytic properties of Borrelia-specific interferon-gamma secreting cells in chronic Lyme borreliosis. J Neuroimmunol 2003, 145:115-26. 10.1016/j.jneuroim.2003.08.037, 14644037.
16. Kang I, Barthold SW, Persing DH, Bockenstedt LK. T-helper-cell cytokines in the early evolution of murine Lyme arthritis. Infect Immun 1997, 65:3107-11. 175438, 9234761.
17. Yin Z, Braun J, Neure L, Wu P, Eggens U, Krause A, Kamradt T, Sieper J. T cell cytokine pattern in the joints of patients with Lyme arthritis and its regulation by cytokines and anticytokines. Arthritis Rheum 1997, 40:69-79. 10.1002/art.1780400111, 9008602.
18. Widhe M, Jarefors S, Ekerfelt C, Vrethem M, Bergstrom S, Forsberg P, Ernerudh J. Borrelia-specific interferon-gamma and interleukin-4 secretion in cerebrospinal fluid and blood during Lyme borreliosis in humans: association with clinical outcome. J Infect Dis 2004, 189:1881-91. 10.1086/382893, 15122525.
19. Jarefors S, Janefjord CK, Forsberg P, Jenmalm MC, Ekerfelt C. Decreased up-regulation of the interleukin-12R beta 2-chain and interferon-gamma secretion and increased number of forkhead box P3-expressing cells in patients with a history of chronic Lyme borreliosis compared with asymptomatic Borrelia-exposed individuals. Clin Exp Immunol 2007, 147:18-27. 1810439, 17177959.
20. Harrington LE, Mangan PR, Weaver CT. Expanding the effector CD4 T cell repertoire: the Th17 lineage. Curr Opin Immunol 2006, 18:349-56. 10.1016/j.coi.2006.03.017, 16616472.
21. Stockinger B, Veldhoen M. Differentiation and function of the Th17 cells. Curr Opin Immunol 2007, 19:281-6. 10.1016/j.coi.2007.04.005, 17433650.
22. Steinman L. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med 2007, 13:139-45. 10.1038/nm1551, 17290272.
23. Sallustro F, Lanzavecchia A. Human Th17 cells in infection and autoimmunity. Microbes Infect 2009, 11:620-4. 10.1016/j.micinf.2009.04.004, 19371794.
24. Burchill MA, Nardelli DT, England DM, DeCoster DJ, Christopherson JA, Callister SM, Schell RF. Inhibition of interleukin-17 prevents the development of arthritis in vaccinated mice challenged with Borrelia burgdorferi. Infect Immun 2003, 71:3437-42. 10.1128/IAI.71.6.3437-3442.2003, 155727, 12761128.
25. Kotloski NJ, Nardelli DT, Peterson SH, Torrealba JR, Warner TF, Callister SM, Schell RF. Interleukin-23 is required for development of arthritis in mice vaccinated and challenged with Borrelia species. Clin Vaccine Immunol 2008, 15:1199-1207. 10.1128/CVI.00129-08, 2519303, 18579699.
26. Codolo G, Amedei A, Steere AC, Papinutto E, Cappon A, Polenghi A, Benagiano M, Paccani SR, Sambri V, Del Prete G, Baldari CT, Zanotti G, Montecucco C, D'Elios MM, de Bernard M. Borrelia burgdorferi NapA-driven Th17 cell inflammation in Lyme arthritis. Arthrit Rheum 2008, 58:3609-17.
27. Murdoch C, Finn A. Chemokine receptors and their role in inflammation and infectious diseases. Blood 2000, 95:3032-43.
28. Luster AD, Ravtech JV. Biochemical characterization of a gamma interferon-inducible cytokine (IP-10). J Exp Med 1987, 166:1084-97. 10.1084/jem.166.4.1084, 2188708, 2443596.
29. Dufour JH, Dziejman M, Liu MT, Leung JH, Lane TE, Luster AD. IFN-γ-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J Immun 2002, 168:3195-3204.
30. Lepej SZ, Rode OD, Jeren T, Vince A, Remenar A, Barsić B. Increased expression of CXCR3 and CCR5 on memory CD4+ T-cells migrating into the cerebrospinal fluid of patients with neuroborreliosis: the role of CXCL10 and CXCL11. J Neuroimmunol 2005, 163(1-2):128-34. 10.1016/j.jneuroim.2005.03.005, 15885315.
31. Muellegger RR, Means TK, Shin JJ, Lee M, Jones KL, Glickstein LJ, Luster AD, Steere AC. Chemokine signatures in the skin disorders of Lyme Borreliosis in Europe: Predominance of CXCL9 and CXCL10 in erythema migrans and acrodermatitis and CXCL13 in lymphocytoma. Infect Immun 2007, 75(9):4621-8. 10.1128/IAI.00263-07, 1951170, 17606602.
32. Vulcano M, Albanesi C, Stoppacciaro A, Bagnati R, D'Amico G, Struyf S, Transidico P, Bonecchi R, Del Prete A, Allavena P, Ruco LP, Chiabrando C, Girolomoni G, Mantovani A, Sozzani S. Dendritic cells as a major source of macrophage-derived chemokine/CCL22 in vitro and in vivo. Eur J Immunol 2001, 31:812-22. 10.1002/1521-4141(200103)31:3<812::AID-IMMU812>3.0.CO;2-L, 11241286.
33. Godiska R, Chantry D, Raport CJ, Sozzani S, Allavena P, Leviten D, Mantovani A, Gray PW. Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells. J Exp Med 1997, 185:1595-604. 10.1084/jem.185.9.1595, 2196293, 9151897.
34. Janeway CA, Travers P, Walport M, Shlomchik MJ. Immunobiology. 2005, Garland Science Publishing.
35. Utgaard JO, Jahnsen FL, Bakka A, Brandtzaeg P, Haraldsen G. Rapid secretion of prestored interleukin 8 from Weibel-Palade bodies of microvascular endothelial cells. J Exp Med 1998, 188(9):1751-1756. 10.1084/jem.188.9.1751, 2212514, 9802986.
36. Kobayashi Y. The role of chemokines in neutrophil biology. Front Biosci 2008, 13:2400-7. 10.2741/2853, 17981721.
37. Gaffen SL. An overview of IL-17 function and signalling. Cytokine 2008, 43:402-7. 10.1016/j.cyto.2008.07.017, 2582446, 18701318.
38. Tibbling G, Link H, Öhman S. Principles of albumin and IgG analyses in neurologic disorders. I. Establishment of reference values. Scand J Clin Lab Invest 1977, 37:385-90.
39. Mygland A, Ljostad U, Fingerle V, Rupprecht T, Schmutzhard E, Steiner I. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol 2010, 17(1):8-16. 10.1111/j.1468-1331.2009.02862.x, 19930447.
40. Peltomaa M, Saxen H, Seppala I, Viljanen M, Pyykkö I. Paediatric facial paralysis caused by Lyme borreliosis: a prospective and retrospective analysis. Scand J Infect Dis 1998, 30:269-75. 10.1080/00365549850160927, 9790136.
41. Tveitnes D, Oymar K, Natas O. Acute facial nerve palsy in children: how often is it Lyme borreliosis?. Scand J Infect Dis 2007, 39:425-31. 10.1080/00365540601105764, 17464865.
42. Widhe M, Skogman BH, Jarefors S, Eknefelt M, Eneström G, Nordwall M, Ekerfelt C, Croner S, Bergström S, Forsberg P, Ernerudh J. Up-regulation of Borrelia-specific IL-4- and IFN-gamma-secreting cells in cerebrospinal fluid from children with Lyme neuroborreliosis. Int Immunol 2005, 17(10):1283-91. 10.1093/intimm/dxh304, 16176932.
43. Henningsson AJ, Malmvall BE, Ernerudh J, Matussek A, Forsberg P. Neuroborreliosis - an epidemiological, clinical and healthcare cost study from an endemic area in the south-east of Sweden. Clin Microbiol Infect 2010, 16(8):1245-51.
44. Nordberg M, Forsberg P, Johansson A, Nyman D, Jansson C, Ernerudh J, Ekerfelt C. Cytotoxic mechanisms may play a role in the local immune response in the central nervous system in neuroborreliosis. J Neuroimmunol 2011, 232(1-2):186-93. 10.1016/j.jneuroim.2010.09.028, 21056912.
45. Awasthi A, Kuchroo VK. Th17 cells: from precursors to players in inflammation and infection. Int Immunol 2009, 21(5):489-98. 10.1093/intimm/dxp021, 2675030, 19261692.
46. Antonelli A, Rotondi M, Fallahi P, Ferrari SM, Paolicchi A, Romagnani P, Serio M, Ferrannini E. Increase of CXC chemokine CXCL10 and CC chemokine CCL2 serum levels in normal ageing. Cytokine 2006, 34(1-2):32-8. 10.1016/j.cyto.2006.03.012, 16697212.